Table 1.
Variables | Overall Survival | |
---|---|---|
HR (95% CI) | P | |
Clinical parameters | ||
Gender | 1.577 (0.62598–1.19) | 0.369 |
Age, year | 1.044 (1.01861–1.046) | 2.73e−06*** |
Race | 9.396 (0.03915–2.076) | 0.215 |
Tumor purity | 0.1471 (0.27283–2.591) | 0.763 |
Pathologic stage | 0.1484 (0.24456–0.491) | 2.53e−09*** |
Analysis parameters | ||
CETN3 | 7.82E+35 (5.835e+07–1.049e+64) | 0.012380* |
DCAF7 | 1.42E+150 (9.363e+04–2.149e+295) | 0.042654* |
GPX4 | 6.37E−40 (1.197e−67–3.385e−12) | 0.005592** |
HNRNPA0 | 2.89E−38 (2.574e−65–3.255e−11) | 0.006532** |
NUP54 | 2.18E+57 (1.668e+15–2.838e+99) | 0.007622** |
SERPINB1 | 2.36E+08 (5.448e+02–1.022e+14) | 0.003598** |
STARD5 | 1.32E+16 (1.019e+00–1.704e+32) | 0.049886* |
TRIM52 | 4.91E+45 (4.245e+13–5.684e+77) | 0.005222** |
C4orf3 | 2.85E+68 (2.846e+11–2.856e+125) | 0.018582* |
C12orf51 | 1.60E−39 (6.178e−73–4.167e−06) | 0.022873* |
C17orf65(ASB16) | 4.40E−59 (3.745e−89–5.165e−29) | 0.000143*** |
C21orf45 | 2.47E−91 (2.804e−181–2.182e−01) | 0.048339* |
p < 0.05,
p < 0.01,
p < 0.001.